{"id":"8dec2cf2-7b32-5dc5-a4a8-2f34578bff41","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-duloxetine-1a2","predicate":"metabolizes","statement":"CYP1A2 catalyzed duloxetine metabolism in the in-vitro experiments.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"66b94e23-9854-59aa-ab49-071a9984c344","mechanism_event_label":"A shared enzyme is a reason to investigate an interaction, not proof DIM lowers the drug level.","subject":{"id":"9b15c13c-a369-5d10-a76a-525e8b19221d","slug":"cyp1a2","display_name":"Human cytochrome P450 1A2","entity_type_key":"protein"},"object":{"id":"77ccdbfd-eff7-5b34-930f-af7664c36b77","slug":"duloxetine","display_name":"Duloxetine","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"66b94e23-9854-59aa-ab49-071a9984c344","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-duloxetine-1a2-event","event_type":"biochemical_relationship","label":"A shared enzyme is a reason to investigate an interaction, not proof DIM lowers the drug level.","description":"CYP1A2 catalyzed duloxetine metabolism in the in-vitro experiments.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9b15c13c-a369-5d10-a76a-525e8b19221d","slug":"cyp1a2","display_name":"Human cytochrome P450 1A2","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"77ccdbfd-eff7-5b34-930f-af7664c36b77","slug":"duloxetine","display_name":"Duloxetine","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dim-research/18307373.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2705ee887855e9dbe738ece57d4ad9d4b3d8cc0d67de45e63c01497a4a215149\", \"start_char\": 0, \"end_char\": 2879, \"text_sha256\": \"2705ee887855e9dbe738ece57d4ad9d4b3d8cc0d67de45e63c01497a4a215149\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Enzyme phenotyping and clinical drug-interaction studies","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Fluvoxamine with oral or intravenous duloxetine","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The clinical exposure change was caused by fluvoxamine, not DIM. The study tests inhibition, not the inverse size of induction.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dim","display_name":"3,3'-Diindolylmethane / DIM","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human enzyme systems and healthy adults","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A shared enzyme is a reason to investigate an interaction, not proof DIM lowers the drug level.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dim-p18307373] In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. (2008). https://pubmed.ncbi.nlm.nih.gov/18307373/ DOI: 10.2165/00003088-200847030-00005","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Duloxetine metabolism and exposure","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"9e27c790-c3ba-5809-9c4b-70553d772463","evidence_kind":"source_excerpt","locator":"Lines 792-803","start_line":792,"end_line":803,"excerpt":"### dim-duloxetine-1a2\nCYP1A2 catalyzed duloxetine metabolism in the in-vitro experiments.\nCondition category: normal\nnutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: A shared enzyme is a reason to investigate an interaction, not proof DIM lowers the drug level.\norganism: Human enzyme systems and healthy adults\ntissue_or_cell_type: Duloxetine metabolism and exposure\nexperimental_model: Enzyme phenotyping and clinical drug-interaction studies\nlimitations: The clinical exposure change was caused by fluvoxamine, not DIM. The study tests inhibition, not the inverse size of induction.\nexposure: Fluvoxamine with oral or intravenous duloxetine\nevidence_span: {\"source_cache\": \"artifacts/dim-research/18307373.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"2705ee887855e9dbe738ece57d4ad9d4b3d8cc0d67de45e63c01497a4a215149\", \"start_char\": 0, \"end_char\": 2879, \"text_sha256\": \"2705ee887855e9dbe738ece57d4ad9d4b3d8cc0d67de45e63c01497a4a215149\"}\n[dim-p18307373] In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. (2008). https://pubmed.ncbi.nlm.nih.gov/18307373/ DOI: 10.2165/00003088-200847030-00005","model_system":"Enzyme phenotyping and clinical drug-interaction studies","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dim-p18307373] In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. (2008). https://pubmed.ncbi.nlm.nih.gov/18307373/ DOI: 10.2165/00003088-200847030-00005","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"b6d70682-97f9-5893-a03c-f9f88836033c","stable_key":"import-182336c6-ed36-5ec6-8a09-25c31096262e","title":"Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"31e14060de904976d2f5d439f2bc9c8a99a72d34626c562c78429025e050d404","revision_id":"611094c1-a9cf-5b9b-b255-ac70b571696a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}